| Name | BBT |
|---|
| Description | BBT is an enhancer of impaired glucose-stimulated insulin secretion (GSIS). BBT exhibits anti-hyperglycemia activity, and protects β-cells from cytokine- or streptozotocin (STZ)-induced cell death in type 2 diabetes models. BBT acts function via cAMP/PKA and long-lasting (L-type) voltage-dependent Ca2+ channel/CaMK2 pathway[1]. |
|---|---|
| Related Catalog | |
| Target |
L-type voltage-dependent Ca2+ channel/CaMK2[1] |
| References |
| Molecular Formula | C18H12BrNO2S |
|---|---|
| Molecular Weight | 386.26 |